Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer

European Journal of Cancer Part A

Volumn 33, Issue 8, 1997, Pages 1216-1220

  Bleiberg, H ^a   Conroy, T ^b   Paillot, B ^c   Lacave, A J ^d   Blijham, G ^k   Jacob, J H ^e   Bedenne, L ^f   Namer, M ^g   De Besi, P ^h   Gay, F ⁱ   Collette, L ^j   Sahmoud, T ^j  

^a JULES BORDET INSTITUTE   (Belgium)

^b CENTRE ALEXIS VAUTRIN   (France)

^c CENTRE HENRI BECQUEREL   (France)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e CENTRE FRANÇOIS BACLESSE   (France)

^f DIJON UNIVERSITY HOSPITAL   (France)

^g CENTRE ANTOINE LACASSAGNE   (France)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ ERASME HOSPITAL   (Belgium)

^j EORTC DATA CENTER   (Belgium)

^k NONE

more..

Author keywords

5 FU; Advanced; Cancer; Chemotherapy; Cisplatin; Oesophageal; Squamous cell carcinoma; Toxicity

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; APLASIA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG EFFICACY; ESOPHAGUS CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEPTICEMIA; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 0030789850     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00088-9     Document Type: Article

References (19)

1. Salts L, Kelsen D. Combined-modality therapy in the treatment of loco-regional oesophageal cancer. Ann Oncol 1992, 3, 793-799.
2. Kelsen D, Minsky B, Smith J, et al. Preoperative therapy for oesophageal cancer/a randomized comparison of chemotherapy versus radiation therapy. J Clin Oncol 1990, 8, 1352-1568.
3. Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992, 326, 1563-1568.
4. Kelsen D, Atiq OT. Therapy of upper gastrointestinal tract cancers. In Haskell CM, ed. Current Problems in Cancer, 15 edn. Boston, MA, Mosby-Year Book, 1991, 239-294.
5. Bleiberg H, Gerard B, Peetrons PH, et al. Measurement of response to chemotherapy using ultrasound in metastatic liver involvement. Eur J Cancer Clin Oncol 1989, 25, 857-859.
6. Measures of therapeutic effect. In Wittes RE, ed. Manual of Oncologic Therapeutics. Philadelphia, J.B. Lippincott Company, 1989-1990, 635-636.
7. Kelsen D. Chemotherapy of oesophageal cancer. Semin Oncol 1984, 11, 154-168.
8. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trials. Biometrics 1975, 31, 103-105.
9. Kaplan EL, Meir P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 457-481.
10. Ajani JA. Contribution of chemotherapy in the treatment of carcinoma of the esophagus: Results and commentary. Semin Oncol 1994, 21, 474-482.
11. Stahl M, Wilke HJ, Meyer HJ, et al. 5-Fluorouracil, folinic acid, etoposide and cisplatin chemotherapy for locally advanced or metastatic carcinoma of the oesophagus. Eur J Cancer 1994, 30A, 325-328.
12. Ajani JA, Ilson DH, Daugherty K, et al. Activity of Taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 1994, 86, 1086-1091.
13. Ajani JA, Ilson D, Bhalla K, et al. Taxol, cisplatin, and 5-FU (TCF): A multi-institutional Phase II study in patients with carcinoma of the esophagus. Proc Am Soc Clin Oncol 1995, 14, 489.
14. Lynch T, Kass F, Kalish LA, et al. Cisplatin, 5-fluorouracil, and etoposide for advanced non-small cell lung cancer. Cancer 1993, 71, 2953-2957.
15. Pfister DG, Bajorin D, Motzger R, et al. Cisplatin, fluorouracil, and leucovorin. Increased toxicity without improved response in squamous cell head and neck cancer. Arch Otolaryngol Head Neck Surg 1994, 120, 89-95.
16. Levine M, Gent M, Hirsh JH, et al. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med 1988, 318, 404-407.
17. Edwards R, Klaus M, Matthews E, et al. Heparin abolishes the chemotherapy-induced increase in plasma fibrinopeptide A levels. Am J Med 1990, 89, 25-28.
18. Kuzel T, Esparaz B, Green D, et al. Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 1990, 65, 885-889.
19. Roussel A, Bleiberg H, Dalesio O, et al. Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trial, Int J Radiat Oncol Biol Phys 1989, 16, 67-72.